Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 277 participants.
Also called NCT02628899
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 277 participants
- Registry
-
NCT02628899
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02628899. Non-randomized; no masking; primary purpose treatment. Start 2016-01 (actual); primary completion 2023-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis
- Condition
- Aortic Stenosis
- Intervention (Device)
- Transfemoral TAVR (transcatheter aortic valve replacement)
- Intervention (Device)
- SAVR
- Lead sponsor
- Medstar Health Research Institute
Record details
- Record id
cardio:ct-nct02628899- Content hash
3fe26d3018fd7f6f296406c830f2ffd93b52ea5184a29d6d521a1ff286d6ab85